Difference between revisions of "Part:BBa K3994011"
Line 3: | Line 3: | ||
<partinfo>BBa_K3994011 short</partinfo> | <partinfo>BBa_K3994011 short</partinfo> | ||
− | PyeaR_HrpR+ | + | promoter |
+ | |||
+ | === Profile === | ||
+ | |||
+ | ==== Name: PyeaR_HrpR+PttB344_HrpS_PJ23105_ttrR+PhrpL_amilGFP_IL10_PJ23104_ttrS ==== | ||
+ | ==== Base Pairs: 7494 bp ==== | ||
+ | ==== Origin: Synthetic ==== | ||
+ | ==== Properties: A biosensor releasing fluorescence only when detecting the IBD marker. ==== | ||
+ | |||
+ | === Usage and Biology === | ||
+ | |||
+ | ==== Background ==== | ||
+ | Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory disease of unknown etiology, including ulcerative colitis (CD) and Crohn’s disease (CD). This chronic disease, which is prone to repeated deterioration, currently lacks unified diagnostic and treatment standards, and is posing a great threat to public health. Drug therapy (anti-inflammatory drugs) is the preferred treatment for IBD. However, studies in the past 10 years have found that 30-50% of IBD patients do not respond to anti-TNF treatment. In addition, after long-term use of anti-inflammatory drugs, the patient's intestinal microbial status changes over time, and the effect may be lost due to drug resistance. Therefore, we need to seek help from other treatments for IBD. | ||
+ | |||
+ | |||
+ | === Construct design === | ||
+ | |||
+ | |||
+ | We can build Boolean logic circuits to combine thiosulfate/tetrasulfate and nitrate biosensors to optimize performance, improve sensor accuracy and enhance robustness, and optimize intestinal inflammation detection (Figure 1). When and only when S2O32-/S4O62- and NO3- are present at the same time, the fluorescent gene is expressed (Figure 1). The fluorescent gene can be replaced with a gene that produce the interleukin-10 (anti-inflammatory factor) for the treatment of IBD. | ||
+ | HrpS is a key functional factor under PttB344 promoter. amilGFP is a fluorescent protein under PhrpL promoter. IL10 is an anti-inflammatory factor. | ||
+ | |||
+ | [[File:T--Shanghai Metro Utd--BBa K4005001-figure2a.png|500px|thumb|center|Figure 1. Boolean gate logic circuit/AND circuit construction...]] | ||
+ | |||
+ | |||
+ | Part1: PyeaR_HrpR, sensing NO3- then release the substance R; | ||
+ | |||
+ | Part2: PttB344_HrpS_PJ23105_ttrR, sensing S4O62- then release the substance S; | ||
+ | |||
+ | Part3: PhrpL_amilGFP_IL10_PJ23104_ttrS, will release fluorescence if sensing both the substances, R and S released from Part 1(HrpR) and Part 2 (HrpS) , respectively. | ||
+ | |||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Revision as of 11:23, 19 October 2021
PyeaR_HrpR+PttB344_HrpS_PJ23105_ttrR+PhrpL_amilGFP_IL10_PJ23104_ttrS
promoter
Profile
Name: PyeaR_HrpR+PttB344_HrpS_PJ23105_ttrR+PhrpL_amilGFP_IL10_PJ23104_ttrS
Base Pairs: 7494 bp
Origin: Synthetic
Properties: A biosensor releasing fluorescence only when detecting the IBD marker.
Usage and Biology
Background
Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory disease of unknown etiology, including ulcerative colitis (CD) and Crohn’s disease (CD). This chronic disease, which is prone to repeated deterioration, currently lacks unified diagnostic and treatment standards, and is posing a great threat to public health. Drug therapy (anti-inflammatory drugs) is the preferred treatment for IBD. However, studies in the past 10 years have found that 30-50% of IBD patients do not respond to anti-TNF treatment. In addition, after long-term use of anti-inflammatory drugs, the patient's intestinal microbial status changes over time, and the effect may be lost due to drug resistance. Therefore, we need to seek help from other treatments for IBD.
Construct design
We can build Boolean logic circuits to combine thiosulfate/tetrasulfate and nitrate biosensors to optimize performance, improve sensor accuracy and enhance robustness, and optimize intestinal inflammation detection (Figure 1). When and only when S2O32-/S4O62- and NO3- are present at the same time, the fluorescent gene is expressed (Figure 1). The fluorescent gene can be replaced with a gene that produce the interleukin-10 (anti-inflammatory factor) for the treatment of IBD. HrpS is a key functional factor under PttB344 promoter. amilGFP is a fluorescent protein under PhrpL promoter. IL10 is an anti-inflammatory factor.
Part1: PyeaR_HrpR, sensing NO3- then release the substance R;
Part2: PttB344_HrpS_PJ23105_ttrR, sensing S4O62- then release the substance S;
Part3: PhrpL_amilGFP_IL10_PJ23104_ttrS, will release fluorescence if sensing both the substances, R and S released from Part 1(HrpR) and Part 2 (HrpS) , respectively.
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal XbaI site found at 1248
Illegal XbaI site found at 1398
Illegal XbaI site found at 3288
Illegal XbaI site found at 3438
Illegal PstI site found at 1236
Illegal PstI site found at 3276 - 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 2062
Illegal NheI site found at 2085
Illegal NheI site found at 5496
Illegal NheI site found at 5519
Illegal PstI site found at 1236
Illegal PstI site found at 3276 - 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 3116
Illegal BamHI site found at 1254
Illegal BamHI site found at 3294 - 23INCOMPATIBLE WITH RFC[23]Illegal XbaI site found at 1248
Illegal XbaI site found at 1398
Illegal XbaI site found at 3288
Illegal XbaI site found at 3438
Illegal PstI site found at 1236
Illegal PstI site found at 3276 - 25INCOMPATIBLE WITH RFC[25]Illegal XbaI site found at 1248
Illegal XbaI site found at 1398
Illegal XbaI site found at 3288
Illegal XbaI site found at 3438
Illegal PstI site found at 1236
Illegal PstI site found at 3276
Illegal NgoMIV site found at 669
Illegal AgeI site found at 142
Illegal AgeI site found at 256
Illegal AgeI site found at 262
Illegal AgeI site found at 901
Illegal AgeI site found at 1776
Illegal AgeI site found at 2329
Illegal AgeI site found at 2335 - 1000COMPATIBLE WITH RFC[1000]